In a study conducted at Queen's University in Kingston, Ontario, researchers compared the effects of inhaled furosemide on dyspnea intensity, airway function, ventilation and other measurements in 20 patients who had COPD.
When compared to placebo, COPD patients who received inhaled furosemide prior to exercise increased their exercise endurance by an average of 21%, and dyspnea intensity during exercise decreased by 0.9 Borg units.
Researchers concluded that "Nebulized furosemide was associated with consistent and potentially clinically important improvements in dyspnea intensity and exercise endurance in patients with advanced COPD".
Read more about the study in the July Issue of Thorax.
Photo of "Breathing Treatment" © flickr.com, user whineendine